A marijuana research bill becomes law, the SAFE Banking Act doesn't, and more.]

National

Marijuana Banking Reform Dead in This Congress. Efforts to provide state-legal marijuana businesses with access to banking and financial services have come to naught in this Congress. The push has been on to get the SAFE Banking Act (HR 1996) through the Senate after it passed the House on seven different occasions, most recently in July. But Senate Majority Leader Chuck Schumer (D-NY) never called it for a vote and he and his Senate allies repeatedly blocked it from being attached to various spending bills as they held out for a full-blown legalization bill. One last chance for the act was the omnibus spending bill passed Tuesday, but it didn't include the act, either. This time, though, it was blocked not by Schumer but by Senate Minority Leader Mitch McConnell (R-KY).

SAFE Banking Act Plus Effort Set for Next Year. Supporters of the SAFE Banking Act (HR 1996) struck out in this Congress, but are determined to get an enhanced version of the bill passed next year. The SAFE Banking Act Plus will contain "important expungement and second amendment rights provisions," said bill sponsor Sen. Jeff Merkley (D-OR). Although the last chance to get the bill passed this year was blocked by Republican Senate leaders, Merkley said, the SAFE Banking Act Plus was a "must pass" in 2023. "We've made so much progress on forging bipartisan consensus,"Merkley said, adding that he "won't rest until we get it done."

Kansas

Kansas Lawmakers Plan to Introduce Medical Marijuana Bill at Start of Session Next Month. Since the end of the last legislative session, members of the Special Committee on Medical Marijuana have been meeting, compiling data, and evaluating research, and now they say they are ready to file a medical marijuana bill at the beginning of the session beginning next month. "I think what I'm going to do is -- and any member is more than welcome -- is to take this information and create the bill," said. Sen. Rob Olson (R-Olathe), chair of the medical marijuana committee. "And I'm going to work on a bill with a couple members and then if anybody wants to sign on in the Senate, they'll be more than able to sign onto that bill and introduce it at the beginning of session." He also called on House lawmakers to file similar legislation. "I think that's probably the best way forward," Olson said. Kansas is one of the 13 states that have still not legalized medical marijuana.

The White House announced last Friday that President Biden (D) had signed into law the bipartisan Medical Marijuana and Cannabidiol Research Expansion Act (HR 8454). The signing was historic; it marked the first time a president has signed a standalone marijuana reform bill into law. Some marijuana reform measures have been passed before, but only as part of much broader appropriations bills.

With lead sponsors Rep. Earl Blumenauer (D-OR), head of the Congressional Cannabis Caucus, and Sen. Dianne Feinstein (D-CA) in their respective chambers, the bill passed by unanimous consent, first in the House and then late last month in the Senate.

The aim of the bill is to facilitate research on marijuana and its potential health benefits. The bill will accomplish this by streamlining the application process for scientific marijuana studies and removing existing barriers for researchers that frequently slow the research process. It will broaden marijuana research by allowing both private companies and research universities to seek DEA licenses to grow their own marijuana for research purposes.

The bill calls on the Department of Health and Human Services (HHS) to study potential therapeutic benefits of the plant, which could have an impact on a rescheduling review Biden ordered in October. But that HHS mandate also includes language requiring research on how marijuana may affect one's ability to drive and the impact of its use on teenage brains.

"Today marks a monumental step in remedying our federal cannabis laws," said Blumenauer and Cannabis Caucus co-chairs Dave Joyce (R-OH), Barbara Lee (D-CA), and Brian Mast R-FL) in a statement after the signing."We celebrate the enactment of this critical and long-overdue legislation, and we know there is much more to do to remedy the ongoing harms of the failed war on drugs."

Among the bill's cosponsors in the Senate was Sen. Charles Grassley (R-IA). Both he and Sen. Feinstein have been among the Senate's most ardent drug warriors going well back into the last century. While this bill is fairly conservative -- it does not directly address rescheduling marijuana or take up the question of access to financial services, let alone legalization -- that both Feinstein and Grassley back it is a sign of how far we've come.

"I've heard directly from Iowans who are desperately in search of treatment options for conditions like child epilepsy," Grassley said in a statement "Unfortunately, many families have resorted to using untested, unregulated derivatives from the marijuana plant as a last resort to treat these conditions. Since 2015, I've pushed to expand medical research into marijuana derivatives such as cannabidiol to better understand their benefits and potential harms. This research is a critical step toward ensuring safe and effective therapies are also consistently regulated like any other prescription drug."

"There is substantial evidence that marijuana-derived medications can and are providing major health benefits," Sen. Feinstein said in a statement. "Our bill will make it easier to study how these medications can treat various conditions, resulting in more patients being able to easily access safe medications. We know that cannabidiol-derived medications can be effective for conditions like epilepsy. This bill will help refine current medical CBD practices and develop important new applications. After years of negotiation, I'm delighted that we're finally enacting this bill that will result in critical research that could help millions," she added.

Now is the time to press for more reform, said Blumenauer.

"Finally, the dam is starting to break," he said in a separate statement. "The passage of my Medical Marijuana and Cannabidiol Research Expansion Act in the House and Senate represents a historic breakthrough in addressing the federal government's failed and misguided prohibition of cannabis."

"As we have seen in state after state, the public is tired of waiting for the federal government to catch up. Nearly half of our nation's population now live in states where adult-use of cannabis is legal. For far too long, Congress has stood in the way of science and progress, creating barriers for researchers attempting to study cannabis and its benefits. At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there are four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able to fully study the impacts of cannabis use."

"The passage of this legislation coming just weeks after the change in President Biden's posture towards cannabis is extraordinarily significant. We must capitalize on this momentum to move subsequent common-sense House-passed bills like the SAFE Banking Act, which finally allows state-legal dispensaries to access banking services and reduce their risk of violent robberies."

There are, indeed, moves afoot to get the SAFE Banking Act passed during the remainder of the lame duck session, but time is running short and the clock is ticking.

A German provincial official seeks to scuttle the federal government's marijuana legalizattion plans, the first marijuana reform legislation passed by Congress is about to be signed into law, and more.

Marijuana Policy

Biden Will Sign Marijuana Research Bill This Week, White House Says. A bill to remove hurdles to marijuana research that passed the House two months ago and the Senate last week will be signed into law this week, the White House said. The bill, HR 8454, is the first marijuana reform legislation to ever pass Congress. The bill will create a more efficient pathway for researchers seeking large quantities of marijuana and will require that the attorney general act withing 60 days to either approve an application or seek more information from the applicant. The bill will also allow researchers to grow their own marijuana.

Law Enforcement

Texas GOP Representative to File Bill to More Harshly Punish Cartels. Conservative Rep. Dan Crenshaw (R-TX) is set to file a bill that would significantly ramp up penalties for people involved with Mexican drug trafficking organizations. The "Declaring War on the Cartels Act" (not yet available on the congressional website) would make crimes related to drug trafficking, human smuggling, sex trafficking, violence, fraud, and immigration offenses committed by cartel members punishable by up to 20 years in federal prison. It would also bar cartel members and their families from admission to the US and allow for the revocation of naturalized citizenship and green cards for people convicted of such activity. It would also allow for the seizure of cartel funds, with those monies going into a special fund to increase enforcement against them. This is just the latest border bill Crenshaw has filed. He has also filed bills to allow for the longer detention of immigrant minors, ban asylum claims except at ports of entry, and to increase the number of ICE prosecutors.

 

International

Colombian Coca Grower Communities in Caqueta Declare Humanitarian Siege to Protest Forced Eradication. Coca growing communities in Caqueta state have mobilized to protest violent forced coca eradication and the national government’s failure five years after peace accords were signed to implement agreements for voluntary coca eradication and alternative development. More than 22,000 families signed up for that program, which is stalled. Peasants pointed to violent eradication campaigns in the Solano, Milán, La Montañita and El Pajuil areas in Caquetá. Peasant groups are calling for dialog to resolve issues that are pitting the peasantry against the military. The Colombian military claimed in August that forced eradication had ended, but the communities in Caqueta beg to differ.

 

Bavarian Health Minister Asks EU to Scuttle Germany’s Marijuana Legalization Plan. Bavarian Health Minister Klaus Holetschek met in Brussels with the European Union’s director-general for migration and home affairs last week in a bid to block the German federal government’s proposal to legalize marijuana. Holetschek is a member of the center-right Union bloc and strongly opposes Chancellor Olaf Scholz’s legalization blueprint. As part of that plan, the German proposal is being sent to the European Commission, the EU’s executive branch, to ensure it is compatible with EU and global drug laws. The German government says it will only move forward with legalization if the plan is approved by the EU. Holetschek warned that "the German government’s planned cannabis legalization doesn’t just endanger health, but I am convinced that it also violates European law."

It has been nearly two years since Oregon voters approved Measure 110, a sweeping drug decriminalization and public health services funding initiative, and it still has strong public support. That could be because it is producing the kinds of results Oregonians want to see.

In voting for Measure 110, Oregonians sought to move the emphasis of drug policy from law enforcement to a public health approach, and that is what they are getting. Drug possession arrests, which had already dropped by half in 2020 because of the pandemic, significantly decreased after Measure 110 took effect on February 1, 2021, according to data from the Oregon Criminal Justice Commission, falling another 65 percent from the 2020 levels in the first six months of 2022.

And Measure 110, which tapped into marijuana tax revenues to fund a broad spectrum of addiction services -- from low-barrier drug treatment and peer support and recovery to overdose prevention and housing and employment support (but not drug treatment covered by Medicaid or insurance) -- is setting the stage for a massive expansion of those services by pumping hundreds of millions of dollars into the field.

Late last month, the Oversight & Accountability Council, the body tasked with overseeing the distribution of the funding, approved the remainder of the initial $302 million made available under Measure 110, and on Tuesday, the Oregon Health Authority announced that it had finished awarding that money to more than 237 service providers in the form of grants.

With the state suffering more than a thousand overdose deaths in the past year, there is criticism that authorities have moved too slowly. Oregon Health Authority behavioral health director Steve Allen acknowledged as much, saying the agency had learned it needed to give more support and technical assistance to the volunteer committee tasked with grantmaking decisions.

"We understand the frustration this caused in our communities," Allen said. "When you do something for the first time you're going to make mistakes."

But now the money is out there, and it will help fund 237 service providers in 36 Behavioral Health Regional Networks (BHRNs), aimed at ensuring that help is available in even the most remote rural corners of the state. That includes 111 groups providing screening and behavioral health needs assessments, 112 groups doing individual intervention planning, 113 groups doing low-barrier drug treatment, 172 groups doing peer support and mentoring, 88 groups providing housing services, 84 groups providing harm reduction services, and 51 groups doing job support.

The money is going to allow these groups to expand their services by hiring and training new staff, securing additional facilities, buying vehicles for mobile support services, and even purchasing housing.

"Measure 110 changes the system so that there is no wrong door to access services," said Tera Hurst, Executive Director of the Health Justice Recovery Alliance. "Thanks to Measure 110, you don't have to get arrested before you are maybe offered help. Measure 110 is changing the addiction recovery service landscape so that regardless of the path, supportive services will be more readily available closer to home."

"It's been a long road, but we're ecstatic to see all of the Measure 110 funding for the 2021-2023 biennium finally being approved and going out to service providers to expand critical addiction services in Oregon communities. This is the first step in ensuring Oregon delivers on its promise of replacing a criminal legal approach to drugs with a public health approach and offering the rest of the country a glimpse of what is ultimately possible when we offer people support instead of punishment," said Kassandra Frederique, Executive Director of the Drug Policy Alliance, which was a key supporter of Measure 110 and which is partnering with the Health Justice Recovery Alliance on implementation.

Even with the slow rollout, Oregonians are liking what they are seeing. A poll released this month by Data for Progress found majority support for Measure 110 in every region of the state -- even the conservative eastern an southwestern areas -- and a strong bipartisan majority who agree that problematic drug use should be treated as a public health issue, not one for the criminal justice system.

When asked whether Measure 110 should remain in place, 58 percent said yes. That included 82 percent of Democrats and 56 percent of independents, but only 31 percent of Republicans.

The polling suggests that tying drug decriminalization to the expansion of recovery services is key to getting it over the finish line. When asked about individual components of the program, 91 percent supported peer mentoring, 90 percent supported employment help, 86 percent supported funding addiction recovery, 84 percent supported housing assistance, but only 62 percent supported harm reduction measures and only 61 percent supported decriminalization itself.

It is almost as if Oregonians made a bargain with themselves: Give us strong measures to aid recovery and we will grudgingly accept such vanguard measures as harm reduction and decriminalizing drugs. These pollsresults should send a clear message to people contemplating future decrim initiatives about how to broaden support for them.